Entrada Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TRDA and other ETFs, options, and stocks.About TRDA
Entrada Therapeutics, Inc. is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company’s Endosomal Escape Vehicle (EEV) therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index.
TRDA Key Statistics
Stock Snapshot
The current Entrada Therapeutics(TRDA) stock price is $11.62, with a market capitalization of 444.86M. The stock trades at a price-to-earnings (P/E) ratio of -3.60.
On 2026-03-05, Entrada Therapeutics(TRDA) stock traded between a low of $11.53 and a high of $12.36. Shares are currently priced at $11.62, which is +0.8% above the low and -6.0% below the high.
The Entrada Therapeutics(TRDA)'s current trading volume is 286.86K, compared to an average daily volume of 214.11K.
In the last year, Entrada Therapeutics(TRDA) shares hit a 52-week high of $12.93 and a 52-week low of $4.93.
In the last year, Entrada Therapeutics(TRDA) shares hit a 52-week high of $12.93 and a 52-week low of $4.93.
Analyst ratings
100%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.